Development of an atovaquone—proguanil combination, trademarked Malarone, during the 1990s has been a major step in addressing the need for antimalarial drugs with targets different from those of agents for which resistance is already rampant in the field (1)....
CITATION STYLE
Vaidya, A. B. (2003). Atovaquone-Proguanil Combination. In Antimalarial Chemotherapy (pp. 203–218). Humana Press. https://doi.org/10.1385/1-59259-111-6:203
Mendeley helps you to discover research relevant for your work.